Tudor Investment Corp ET AL Has $9.27 Million Stock Position in National Health Investors, Inc. $NHI

Tudor Investment Corp ET AL lifted its holdings in National Health Investors, Inc. (NYSE:NHI) by 189.8% in the 3rd quarter, Holdings Channel reports. The firm owned 116,570 shares of the real estate investment trust’s stock after buying an additional 76,339 shares during the quarter. Tudor Investment Corp ET AL’s holdings in National Health Investors were worth $9,267,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. EverSource Wealth Advisors LLC lifted its position in shares of National Health Investors by 244.1% in the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after buying an additional 288 shares during the last quarter. Advisory Services Network LLC acquired a new stake in National Health Investors in the 3rd quarter worth approximately $65,000. Triumph Capital Management bought a new stake in National Health Investors during the third quarter worth approximately $66,000. Farther Finance Advisors LLC grew its holdings in National Health Investors by 24.9% during the third quarter. Farther Finance Advisors LLC now owns 1,128 shares of the real estate investment trust’s stock valued at $90,000 after purchasing an additional 225 shares during the last quarter. Finally, Smartleaf Asset Management LLC raised its position in shares of National Health Investors by 212.4% in the third quarter. Smartleaf Asset Management LLC now owns 1,206 shares of the real estate investment trust’s stock valued at $95,000 after purchasing an additional 820 shares during the period. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Stock Performance

Shares of NYSE NHI opened at $81.65 on Monday. The firm has a market capitalization of $3.96 billion, a price-to-earnings ratio of 27.04, a PEG ratio of 4.44 and a beta of 0.65. National Health Investors, Inc. has a one year low of $66.41 and a one year high of $91.38. The business has a fifty day simple moving average of $84.20 and a 200 day simple moving average of $79.65. The company has a current ratio of 6.90, a quick ratio of 6.90 and a debt-to-equity ratio of 0.76.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.01). The business had revenue of $105.82 million during the quarter, compared to the consensus estimate of $95.12 million. National Health Investors had a net margin of 37.81% and a return on equity of 9.56%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the firm earned $1.24 EPS. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. Sell-side analysts expect that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.92 per share. The ex-dividend date is Tuesday, March 31st. This represents a $3.68 dividend on an annualized basis and a yield of 4.5%. National Health Investors’s dividend payout ratio (DPR) is currently 121.85%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on NHI. Deutsche Bank Aktiengesellschaft cut shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price objective for the company. in a research note on Tuesday, January 20th. Wells Fargo & Company upped their price target on shares of National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Tuesday, November 25th. KeyCorp lifted their price objective on National Health Investors from $80.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, December 4th. Weiss Ratings restated a “buy (b)” rating on shares of National Health Investors in a research note on Monday, December 29th. Finally, Truist Financial lifted their price target on National Health Investors from $85.00 to $92.00 and gave the stock a “buy” rating in a research report on Thursday, March 12th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $86.67.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.